Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept vs Usual DMARDs in RA
NCT00422227Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jun 2007
- Primary completion
- Mar 2009
- Modality
- Fc-Fusion Proteins
- Countries
- 8
01
Overview
A Phase 4 trial of etanercept in rheumatoid arthritis (RA), sponsored by Pfizer. Started Jun 2007; status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00422227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00422227.